Grant: Fellowship - Priority Announcement: Kidney Cancer (SHOPP)
University of Toronto
$60,000.00
VHL-mediated regulation of JAK/STAT pathway in kidney cancer
EF 2010-11
Résumé
Our research team recently discovered a novel link between two genes, the von Hippel-Lindau (VHL) and the Janus kinase 2 (JAK2) that have important roles in the development of cancer. The VHL gene is a tumour suppressor gene that helps to control cell growth and proliferation. Abnormalities or mutations of the VHL gene result in the development of numerous cancers, including those of the brain, eye, and kidney. In the general population VHL gene mutations are very common in the development of kidney cancer, one of the most resistant cancers to conventional anti-cancer therapies. The significant discovery made by our research team is that the two proteins are physically linked, and that VHL actually regulates the activity of JAK2. My research objectives are to elucidate the precise molecular mechanisms by which VHL regulates JAK2 in kidney cancer with the supposition that the lessons learned from my research will provide better understanding of kidney cancer development and progression, and ultimately aid in the development of novel cancer therapies.
Programme
Fellowship - Priority Announcement: Kidney Cancer (SHOPP)
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
215902
Name
Bunda Severa
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Partnername
Kidney Cancer Canada Association (Cambridge, ON)
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Fellowships - Post-PhD
Projecttitle
VHL-mediated regulation of JAK/STAT pathway in kidney cancer
Programtype2
Fellowship Programs
Orgnameinp2
University of Toronto
Cihramount2
$60,000
Cihrequipment2
$0
Programname2
Fellowship - Priority Announcement: Kidney Cancer (SHOPP)
Keyworddelim
E3 Ubiquitin Ligase; Jak2; Jak2-Stat5 Signaling; Renal Cell Carcinoma (Rcc); Socs1; Von Hippel-Lindau Tumor Suppressor Protein (Pvhl)
Abstract
Our research team recently discovered a novel link between two genes, the von Hippel-Lindau (VHL) and the Janus kinase 2 (JAK2) that have important roles in the development of cancer. The VHL gene is a tumour suppressor gene that helps to control cell growth and proliferation. Abnormalities or mutations of the VHL gene result in the development of numerous cancers, including those of the brain, eye, and kidney. In the general population VHL gene mutations are very common in the development of kidney cancer, one of the most resistant cancers to conventional anti-cancer therapies. The significant discovery made by our research team is that the two proteins are physically linked, and that VHL actually regulates the activity of JAK2. My research objectives are to elucidate the precise molecular mechanisms by which VHL regulates JAK2 in kidney cancer with the supposition that the lessons learned from my research will provide better understanding of kidney cancer development and progression, and ultimately aid in the development of novel cancer therapies.
Competitiondate
201010
Approvedterm2
2 yrs 8 mths
Pinamesdelim
Bunda, Severa
Approvedterm
2 ans 8 mois
Cihrcontribution2
SPIR~ $60,000~ $0~